Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy

被引:10
|
作者
Cassidy, Richard J. [1 ,2 ]
Nour, Sherif G. [2 ,3 ]
Liu, Tian [1 ,2 ]
Switchenko, Jeffrey M. [2 ,4 ]
Tian, Sibo [1 ,2 ]
Ferris, Matthew J. [1 ,2 ]
Press, Robert H. [1 ,2 ]
Zhong, Jim [1 ,2 ]
Abugideiri, Mustafa [1 ,2 ]
Rossi, Peter J. [1 ,2 ]
Jani, Ashesh B. [1 ,2 ]
机构
[1] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Radiol, Winship Canc Inst, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Biostat & Bioinformat, Winship Canc Inst, Atlanta, GA 30322 USA
关键词
3-DIMENSIONAL CONFORMAL RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; RADICAL PROSTATECTOMY; PENILE BULB; BRACHYTHERAPY; ASSOCIATION; LOCALIZATION; PREVENTION;
D O I
10.1016/j.prro.2017.08.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Efforts to define the neurovascular bundle (NVB) for prostate radiation have varied. In this series, we sought to determine the reproducibility and reliability of contouring the classical posterolateral NVB on dedicated pelvic magnetic resonance imaging (MRI) scans. Methods and materials: A total of 120 NVB structures were defined on 10 3-Tesla pelvic MRI scans in patients with prostate cancer but without extraprostatic extension. One pelvic radiologist served as the expert in contouring the right and left NVB for each case. Five radiation oncologists, with varying levels of experience, contoured the right and left NVBs on these same cases. The intraclass correlation coefficient across each rater and the expert, Pearson correlation coefficient between each rater and the expert, and the Dice similarity coefficient (DSC) between each rater and the expert were calculated to evaluate contour agreement and overlap. Results: The overall intraclass correlation coefficient was 0.89 (95% confidence interval [CI], 0.81-0.95). The Pearson correlation coefficient was 0.95 (95% CI, 0.86-0.98) for rater 1, 0.98 (95% CI, 0.95-0.99) for rater 2, 0.94 (95% CI, 0.86-0.98) for rater 3, 0.98 (95% CI, 0.95-0.99) for rater 4, and 0.84 (95% CI, 0.63-0.93) for rater 5. The mean DSC was 0.72 (standard deviation [SD], 0.07) for rater 1, 0.72 (SD, 0.06) for rater 2, 0.73 (SD, 0.09) for rater 3, 0.74 (SD, 0.09) for rater 4, and 0.68 (SD, 0.13) for rater 5. Overall, across all raters, the average DSC was 0.72 (SD, 0.09). Conclusions: The classic posterolateral NVB can be accurately and reliably contoured on 3-Tesla pelvic MRI scans by radiation oncologists. (C) 2017 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E125 / E131
页数:7
相关论文
共 50 条
  • [21] Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey
    Rowe, Lindsay S.
    Mandia, Jeremy J.
    Salerno, Kilian E.
    Shankavaram, Uma T.
    Das, Shaoli
    Escorcia, Freddy E.
    Ning, Holly
    Citrin, Deborah E.
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (05)
  • [22] NEUROVASCULAR BUNDLE INVOLVEMENT CAN NOT BE ASSESSED ACCURATELY WITH ROUTINE PREOPERATIVE EVALUATION IN PROSTATE CANCER PATIENTS
    Akbulut, Z.
    Kandemir, O.
    Atmaca, A. F.
    Demirci, A.
    Dogan, B.
    Canda, A. E.
    Balbay, M. D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 562 - 563
  • [23] Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer
    Felix Preisser
    Giorgio Gandaglia
    Farid Arad
    Pierre I. Karakiewicz
    Marco Bandini
    Raisa S. Pompe
    Francesco Montorsi
    Markus Graefen
    Hartwig Huland
    Alberto Briganti
    Derya Tilki
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 193 - 201
  • [24] Neurovascular Bundle Infiltration Can Explain Local Relapses Using Conformal Radiotherapy of Prostate Cancer
    Johansson, Andreas K.
    Lennernas, Bo
    Isacsson, Ulf
    ANTICANCER RESEARCH, 2017, 37 (04) : 1825 - 1830
  • [25] Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer
    Preisser, Felix
    Gandaglia, Giorgio
    Arad, Farid
    Karakiewicz, Pierre I.
    Bandini, Marco
    Pompe, Raisa S.
    Montorsi, Francesco
    Graefen, Markus
    Huland, Hartwig
    Briganti, Alberto
    Tilki, Derya
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 193 - 201
  • [26] Curative radiation therapy in prostate cancer
    Harmenberg, Ulrika
    Hamdy, Freddie C.
    Widmark, Anders
    Lennernas, Bo
    Nilsson, Sten
    ACTA ONCOLOGICA, 2011, 50 : 98 - 103
  • [27] Postprostatectomy radiation therapy for prostate cancer
    Abramowitz, Matthew C.
    Pollack, Alan
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (01) : 15 - 22
  • [28] RADIATION-THERAPY OF PROSTATE CANCER
    TAYLOR, WJ
    RICHARDSON, RG
    HAFERMANN, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1977, 2 : 55 - 55
  • [29] Adaptive radiation therapy for prostate cancer
    Nuver, TT
    Hoogeman, MS
    Remeijer, P
    Van Herk, M
    Lebesque, JV
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S156 - S157
  • [30] Radiation Therapy in Oligometastatic Prostate Cancer
    Chinniah, Siven
    Stish, Bradley
    Costello, Brian A.
    Pagliaro, Lance
    Childs, Daniel
    Quevedo, Fernando
    Lucien, Fabrice
    Bryce, Alan
    Park, Sean S.
    Orme, Jacob J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 684 - 692